CD8A and neoplasm: It is interesting that the Nr-CWS treated tumor-bearing mice showed significantly up-regulated percentages of tumor infiltrating CD8+ T and NK cells at the early stage (treated for 7 days; Figure 1C, Supplementary Figure S1E), and higher spleen index (treated for 14 days; Figure 1D).